Zydus Cadila to begin vaccine trials for kids above 5 yrs soon

So far, no other vaccine has been approved globally for children below 12 years.Sohini Das reports.  IMAGE: A beneficiary receives a dose of the Covid-19 vaccine at a vaccination centre in......

Oxford jabs effective against severe Covid: US trial

A large trial in the United States and two South American countries of the Oxford-AstraZeneca vaccine has shown 79 per cent efficacy rate at preventing symptomatic COVID-19 and 100 per cent......

Serum Institute began its journey in a small lab in stud farm

The Covishield maker's forte throughout the past half a century has been a combination of affordable vaccines and high volumes. Its tetanus, diphtheria and measles vaccines are known throughout the......

Oxford/AstraZeneca COVID-19 vaccine approved by UK regulator

The coronavirus vaccine designed by scientists at the University of Oxford and produced by AstraZeneca was on Wednesday approved for human use by the United Kingdom’s independent regulator.......

Serum Institute to provide Covid vaccine at Rs 250 a dose

Serum Institute of India plans to make 300 million doses of AZD1222 by December, and will begin phase-2 trials soon. It has also tied up with Novavax for development and commercialisation of its......

Meet Adar Poonawala, India's COVID-19 vaccine man

Serum Institute is investing $200 million to create capacities for the COVID-19 vaccine.Sohini Das profiles its 39-year-old CEO. IMAGE: Adar Poonawalla, right, and his father Dr Cyrus S......

'We will price Covid vaccine below Rs 1,000'

'Once the trials are successful in India and the UK, we are certain that COVISHIELD will be one of the first vaccines to be introduced.' IMAGE: The Reference Center for Special Immunobiologicals......